Probable risk of tumour induction after retro-orbital irradiation for Graves' ophthalmopathy

A. Snijders-Keilholz*, R. J.W. De Keizer, B. M. Goslings, E. W.C.M. Van Dam, J. Th M. Jansen, J. J. Broerse

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Retrobulbar irradiation for Graves' ophthalmopathy is considered as a safe treatment and has recently been recommended as the initial treatment for patients with moderately severe eye problems. However, calculations using risk factors presently known reveal a theoretical risk of radiation-induced cancer of 1.2%. Therefore, the authors suggest that this treatment should be reserved for the elderly patient, for example above the age of 40-50 years.

Original languageEnglish
Pages (from-to)69-71
Number of pages3
JournalRadiotherapy and Oncology
Volume38
Issue number1
DOIs
Publication statusPublished - 1 Jan 1996

Cite this

Snijders-Keilholz, A., De Keizer, R. J. W., Goslings, B. M., Van Dam, E. W. C. M., Jansen, J. T. M., & Broerse, J. J. (1996). Probable risk of tumour induction after retro-orbital irradiation for Graves' ophthalmopathy. Radiotherapy and Oncology, 38(1), 69-71. https://doi.org/10.1016/0167-8140(95)01670-8